Expression of FasL and Fas protein and their soluble form in patients with hypersensitivity pneumonitis

International Archives of Allergy and Immunology

Volumn 122, Issue 3, 2000, Pages 209-215

  Kuwano, Kazuyoshi ^a,c   Hagimoto, Naoki ^a   Kawasaki, Masayuki ^a   Nakamura, Norio ^b   Shirakawa, Kamon ^b   Maeyama, Takashige ^a   Hara, Nobuyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b MOCHIDA PHARMACEUTICAL CO   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Fas; Fas ligand; Hypersensitivity pneumonitis

Indexed keywords

ALLERGEN; FAS ANTIGEN; FAS LIGAND;

ALLERGIC PNEUMONITIS; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIOID CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LUNG ALVEOLITIS; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG GRANULOMA; LUNG LAVAGE; LYMPHOCYTIC INFILTRATION; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033909857     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024399     Document Type: Article

References (27)

1. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991;66:233-243.
2. Suda T, Takahashi T, Golstein T, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993;75:1169-1178.
3. Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K, Nagata S: Expression of the Fas ligand in cells of T cell lineage. J Immunol 1995;154:3806-3813.
4. Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA, Nagata S: The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 1992;148:1274-1279.
5. Lowin B, Hahne M, Mattmann C, Tschopp J: Cytotoxic-T cell cytotoxicity is mediated through perform and Fas lytic pathways. Nature 1994;370:650-652.
6. Kagi D, Vignaux F, Ledermann B, Bürki K, Depraetere V, Nagata S, Hengartner H, Golstein P: Fas and perform pathways as major mechanisms of T-cell mediated cytotoxicity. Science 1994;265:528-530.
7. Jun HS, Yoon CS, Zhytnuik L, van Rooijen N, Yoon JW: The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Exp Med 1999;189:347-358.
8. Esser MT, Dinglasan RD, Krishnamurthy B, Gullo CA, Graham MB, Braciale VL: IL-2 induces Fas ligand/Fas (CD95L/CD95) cytotoxicity in CD8+ and CD4+ T lymphocyte clones. J Immunol 1997;158:5612-5618.
9. Waldner H, Sobel RA, Howard E, Kuchroo VK: Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. J Immunol 1997;159:3100-3103.
10. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mountz, JD: Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994;263: 1759-1762.
11. Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi K, Mizuki M, Tagawa S, Ohga S, Hatake K, Drummond AH, Nagata S: Fas ligand in human serum. Nat Med 1996; 2:319-322.
12. Kayagaki N, Kawasaki A, Ebata T, Ohmoto H, Ikeda S, Inoue S, Yoshino K, Okumura K, Yagita H: Metalloproteinase-mediated release of human ligand. J Exp Med 1995;182:1777-1783.
13. Tanaka M, Suda T, Takahashi T, Nagata S: Expression of the functional soluble form of Fas ligand in activated lymphocytes. EMBO J 1995;14:1129-1135.
14. Kunitake R, Kuwano K, Miyazaki H, Hagimoto N, Nomoto Y, Hara N: Apoptosis in the course of granulomatous inflammation in pulmonary sarcoidosis. Eur Respir J 1999;13: 1329-1337.
15. Richardson HB, Bernstein IL, Fink JN, Hunninghake GW, Novey HS, Reed CE, Salvaggio JE, Schuiler MR, Schwaltz HJ, Stechschulte DJ: Guidelines for the clinical evaluation of hypersensitivity pneumonitis. J Allergy Clin Immunol 1989;84:839-844.
16. American Thoracic Society: Standardization of spirometry - 1994 update. Am J Respir Crit Care Med 1995;152:1107-1136.
17. American Thoracic Society: Single-breath carbon monoxide diffusing capacity (transfer factor): Recommendations for a standard technique - 1995 update. Am J Respir Crit Care Med 1995;152:2185-2198.
18. Hagimoto N, Kuwano K, Kawasaki M, Yoshimi M, Kaneko Y, Kunitake R, Maeyama T, Tanaka T, Hara N: Induction of interleukin-8 secretion and apoptosis in bronchiolar epithelial cells by Fas ligation. Am J Respir Cell Mol Biol 1999;21:436-445.
19. Kunitake R, Kuwano K, Miyazaki H, Kawasaki M, Hagimoto N, Fujita M, Kaneko Y, Hara N: The expression of p53, p21 (Waf1/Cip1/ Sdi1) and Fas antigen in interstitial pneumonia associated with collagen vascular diseases and granulomatous lung diseases. Eur Respir J 1998;12:920-925.
20. Leithäuser F, Dhein J, Mechtersheimer G, Koretz K, Brüderlein S, Henne C, Schmidt A, Debatin KM, Krammer PH, Möller P: Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 1993;69:415-429.
21. Tanaka M, Suda T, Yatomi T, Nakamura N, Nagata S: Lethal effect of recombinant human Fas ligand in mice pretreated with Propionibacterium acnes. J Immunol 1997;158:2303-2309.
22. Schneider P, Holler N, Bodmer J, Hahne M, Frei K, Fontana A, Tschopp J: Conversion of membrane bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver injury. J Exp Med 1998:187:1205-1213.
23. Solorzano CC, Ksontini R, Pruitt JH, Hess PJ, Edwards PD, Kaibara A, Abouhamze A, Auffenberg T, Galardy RE, Vauthey JN, Copeland III EM, Edwards III CK, Lauwers GY, ClareSalzler M, MacKay SLD, Moldawer LL, Lazarus DD: Involvement of 26-kDa cell-associated TNF-alpha in experimental hepatitis and exacerbation of liver injury with a matrix metalloproteinase inhibitor. J Immunol 1997;158: 414-419.
24. Tanaka M, Itai T, Adachi M, Nagata S: Down-regulation of Fas ligand by shedding. Nat Med 1998;4:31-36.
25. Suda T, Hashimoto H, Tanaka M, Ochi T, Nagata S: Membrane Fas ligand kills human peripheral blood T lymphocytes and soluble Fas ligand blocks the killing. J Exp Med 1997; 186:2045-2050.
26. Kuwano K, Miyazaki H, Hagimoto N, Kawasaki M, Fujita M, Kunitake R, Kaneko Y, Hara N: The involvement of Fas-Fas ligand pathway in fibrosing lung diseases. Am J Respir Cell Mol Biol 1999;20:53-60.
27. Matute-Bello G, Liles WC, Steinberg KP, Kiener PA, Mongovin S, Chi EY, Jonas M, Martin TR: Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J Immunol 1999;163:2217-2225.